Improved early continence following robotic-assisted radical prostatectomy with a concurrent retropubic vascularised fascia sling (RoboSling)

Fallot J1, Kim S1, Stanislaus C1, Steffans D1, Mak G1, Virk A1, Jackson S1, Thanigasalam R2, Leslie S1

Research Type

Clinical

Abstract Category

Male Stress Urinary Incontinence (Post Prostatectomy Incontinence)

Abstract 437
Video 2: Urethra and Gender Reconstruction
Scientific Podium Video Session 28
On-Demand
Incontinence Male Quality of Life (QoL) Surgery Stress Urinary Incontinence
1. royal prince alfred hospital, 2. concord repatriation general hospital
Presenter
Links

Abstract

Introduction
Urinary incontinence remains a major concern for patients when undergoing a radical prostatectomy. Although long-term continence rates exceed 90%, early continence rates are much lower, ranging between 28% to 74% at 3 months. We describe a novel technique to improve urinary function by using an autologous vascularized fascial sling (RoboSling) placed underneath the urethrovesical anastomosis at the time of robot-assisted radical prostatectomy (RARP).
Design
We provide a step-by-step description of our RoboSling technique. Also included are the results of a prospective, non-randomised cohort study comparing continence rates between patients who underwent a standard RARP and those who in addition to RARP had a RoboSling procedure performed concurrently. In our hospital, between December 2016 and October 2019, 176 patients underwent RARP done by 5 different surgeons. The RoboSling procedures were performed by one surgeon. We compared pad usage and continence rates using the EPIC-urinary domain questionnaire, as well as clinical and oncological outcomes in 146 patients without a RoboSling and 30 with a RoboSling.
Results
One hundred and seventeen patients (response rate 80%) filled in their 3 months postoperative questionnaires. Baseline characteristics did not differ between the two groups (see table). At three months, zero pad usage (p=0,010) was significantly higher in the RoboSling group. At 3 months, zero pad usage and continence rates remained higher in the RoboSling group. Zero pad use was 47% with and 17% without a RoboSling. Length of stay and complication rate did not differ between the two groups. Blood loss was significantly lower in the RoboSling group (P=0.015).
Conclusion
Patients undergoing a RoboSling procedure at the time of robotic radical prostatectomy experienced an earlier return to continence compared to the control arm without a higher complication or positive surgical margin rate. A randomized controlled trial with multiple surgeons performing the RoboSling procedure is now underway to further assess the merits of this novel technique.
Figure 1
Disclosures
Funding No funding Clinical Trial Yes Registration Number Australian Clinical Trials, ACTRN12618002058257 RCT Yes Subjects Human Ethics Committee Sydney Local Health District Ethics Helsinki Yes Informed Consent Yes
20/11/2024 07:54:46